Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Role of Exosomes in Parkinson?s Disease and Other Synucleinopathies
EF 2019-20
Résumé
"Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are neurodegenerative diseases called synucleinopathies, where alpha-synuclein (alpha-syn) forms sticky deposits in brain cells. This misfolded alpha-syn causes healthy alpha-syn to clump and spread throughout the brain years before clinical symptoms appear. Therefore, it is important to investigate biomarkers that allow us to identify these patients before they display symptoms. Small blood-borne vesicles known as exosomes could serve as a potential biomarker. Exosomes carry alpha-syn from the brain to blood where they can be easily measured, and correlate with disease severity, supporting the idea that exosomes could be used as a diagnostic marker. Exosomes from patients with DLB have been shown to spread alpha-syn pathology in mice, but it is unclear whether exosomes from other synucleinopathies can spread pathology as well. We and others have shown that transgenic mice that overexpress a mutant form of alpha-syn can develop clinical symptoms when their brains are injected with material from human MSA brains. These studies suggest that blood and brain exosomes from synucleinopathy mice are responsible for spreading disease. My aims are to 1) isolate and characterize blood and brain exosomes from affected mice and 2) inject unaffected mice with these exosomes to test whether disease is induced. To date, we have successfully isolated and characterized exosomes from affected mice and have injected healthy mice. As hypothesized, the injected mice developed neurological symptoms and will be analyzed for brain pathology. This project will further our knowledge on exosomes and their role in the spread of alpha-syn. It will advance our understanding of utilizing exosomes as a biomarker for synucleinopathies."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
428849
Name
Hamzeh Amir
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of Exosomes in Parkinson?s Disease and Other Synucleinopathies
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha Synuclein; Exosomes; Multiple System Atrophy; Neurodegeneration; Neuronal Communication; Neurotransmission; Parkinson'S Disease; Synucleinopathies
Abstract
"Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are neurodegenerative diseases called synucleinopathies, where alpha-synuclein (alpha-syn) forms sticky deposits in brain cells. This misfolded alpha-syn causes healthy alpha-syn to clump and spread throughout the brain years before clinical symptoms appear. Therefore, it is important to investigate biomarkers that allow us to identify these patients before they display symptoms. Small blood-borne vesicles known as exosomes could serve as a potential biomarker. Exosomes carry alpha-syn from the brain to blood where they can be easily measured, and correlate with disease severity, supporting the idea that exosomes could be used as a diagnostic marker. Exosomes from patients with DLB have been shown to spread alpha-syn pathology in mice, but it is unclear whether exosomes from other synucleinopathies can spread pathology as well. We and others have shown that transgenic mice that overexpress a mutant form of alpha-syn can develop clinical symptoms when their brains are injected with material from human MSA brains. These studies suggest that blood and brain exosomes from synucleinopathy mice are responsible for spreading disease. My aims are to 1) isolate and characterize blood and brain exosomes from affected mice and 2) inject unaffected mice with these exosomes to test whether disease is induced. To date, we have successfully isolated and characterized exosomes from affected mice and have injected healthy mice. As hypothesized, the injected mice developed neurological symptoms and will be analyzed for brain pathology. This project will further our knowledge on exosomes and their role in the spread of alpha-syn. It will advance our understanding of utilizing exosomes as a biomarker for synucleinopathies."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hamzeh, Amir
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~